MedPath

Effects on the clinical evolution of patients with respiratory infection secondary to the Sars-CoV-2 virus, when they are maintaining communication with family/friends through mobile devices compared to patients not having an option of communicatio

Not Applicable
Suspended
Conditions
COVID-19
Registration Number
SLCTR/2020/026
Lead Sponsor
Center for Research in Policies, Population and Health (CIPPS), of the Faculty of Medicine, National Autonomous University of Mexico (UNAM), Mexico
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

• Men and women
• Older than 18 years
• Patients with lung infection by the Sars-Cov-2 virus (Covid-19)
• With O2 saturation greater than 70% and less than 89% upon admission to the emergency room
• Have family or friends to call
• The family member or friends have a mobile device to receive video calls

Exclusion Criteria

Intubated or with respiratory failure that prevents them from participating
• Alterations in the state of consciousness.
• Intellectual, verbal, hearing disability
• Previous psychiatric or mental disorders (anxiety, depression, bipolar, dementia, etc.)
• Voluntary discharge

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The average number of days of confinement <br><br><br> [Measured during the hospital stay up to discharge]<br>Types of complications occurred during the hospital stay [Measured at discharge of patient]<br>Outcome of the disease [Measured at discharge of patient]<br>
Secondary Outcome Measures
NameTimeMethod
The total cost of bed days will be measured + cost of drugs used + cost of laboratory and cabinet tests = Total Cost, for each of the groups [Measured at hospital discharge of patient]<br>
© Copyright 2025. All Rights Reserved by MedPath